Stocks to Watch: Gamestop, Universe Pharmaceuticals, Healthcare Triangle

Dow Jones
06/27
 

GameStop forecast a jump in adjusted earnings before interest, taxes, depreciation, and amortization for the current fiscal year. The company said it expects adjusted Ebitda for the fiscal year ending Jan. 30, 2027, to be upwards of $600 million, compared to $345.4 million for the previous fiscal year. The forecast comes after the company reported a higher profit and rising sales in its most recent quarter and approved a $2 billion stock buyback. Shares ticked up 2.2% to $22.24 in late trading.

Universe Pharmaceuticals agreed to acquire Best Praise International Limited in an all-stock deal valued at $10.8 million. Under the deal, which is expected to close in the third quarter, Universe will pay for the acquisition with about 4.8 million shares of its common stock. Shares of Universe more than tripled to $9.34 in after-hours trading.

Healthcare Triangle entered a securities exchange agreement related to its acquisition of SecureKloud Technologies's assets. The company said it agreed to issue about 2.8 million shares of its common stock to SecureKloud in exchange for all of SecureKloud's right, title and interest in the 1.6 million shares of Series B preferred stock that Healthcare Triangle had previously issued under a 2024 agreement. The stock gained in after-hours trading before turning negative, and were recently down 5.9% at $1.92.

 

Write to Kelly Cloonan at kelly.cloonan@wsj.com

(END) Dow Jones Newswires

June 26, 2026 18:50 ET (22:50 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10